Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis. (2016)
Attributed to:
DECIPHer: Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep.28497
PubMed Identifier: 26864802
Publication URI: http://europepmc.org/abstract/MED/26864802
Type: Journal Article/Review
Volume: 63
Parent Publication: Hepatology (Baltimore, Md.)
Issue: 6
ISSN: 0270-9139